Characteristics of adolescents with T2D cases reporting ADRs to metformin in FAERS. by Mengsi Peng (12882734)

Subjects:

Flowchart of case selection process from the FAERS database. by Mengsi Peng (12882734)

Subjects:

Visual summary of metformin-associated ADRs in adolescents with T2D. by Mengsi Peng (12882734)

Subjects:

Table1_Adverse event signal mining and severe adverse event influencing factor analysis of Lumateperone based on FAERS database.docx by Yanjing Zhang (401134)

“…Background<p>Lumateperone has been approved by the Food and Drug Administration (FDA) for the treatment of schizophrenia in adults since 2019, however, there is still a lack of data report on adverse reactions in real-world settings. Conducting data mining on adverse events (AEs) associated with Lumateperone and investigating the risk factors for serious AEs can provide valuable insights for its clinical practice.…”

Four grid table. by Xiaoling Zhong (181270)

Subjects:

Flowchart depicting the selection of the study population. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age < 18). by Xiaoling Zhong (181270)

Subjects:

Basic information and patient characteristics according to the report. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the preferred term level in the FAERS database. by Xiaoling Zhong (181270)

Subjects:

Four major algorithms used for signal detection. by Xiaoling Zhong (181270)

Subjects:

Time to onset of AEs in male and female patients receiving finasteride therapy. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the SOC level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the SOC level by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration in female at the PT level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration in male at the PT level. by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age = 18-65). by Xiaoling Zhong (181270)

Subjects:

Signal strength of reports of finasteride administration at the PT level (age>=65). by Xiaoling Zhong (181270)

Subjects:

Clinical characteristics of reports with finasteride as the primary suspected drug from the FAERS database. by Xiaoling Zhong (181270)

Subjects:

Sex-differentiated risk signal volcano plot for finasteride. by Xiaoling Zhong (181270)

Subjects:

Results of multiple logistic regression analysis to identify potential factors associated with the successful reduction of HPC and F+ coliphage in the POU UVC LED effluent. Single... by Hania Zanib (21864477)

Subjects: